viatris semaglutide Wegovy® - Prefilled Pen Use of new diet drugs
Description
Equally importantly, GLP-1 receptor agonist use was associated with some increased risks compared to usual care with other treatments
Paula Bilica with IMAXweightloss
According to the Wegovy SmPC, nausea, vomiting, diarrhoea, and constipation are all very common side effects (affecting more than 1 in 10 people)
:max_bytes(150000):strip_icc()/VWH-Wegovy-receives-FDA-approval-for-treating-MASH-51d3bd1a89894b5e80b8a1a093d30a63.jpg)
Almost 30 lb gone
According to clinical trial data for orforglipron, participants achieved an average reduction in body weight of 14.7% over 72 weeks
